Functionally graded composite coatings for biomedical implants: Design principles, fabrication strategies and future perspectives

Functionally graded coatings (FGCs) have emerged as a promising strategy to address the persistent challenges associated with biomedical implants, including mechanical mismatch, poor osseointegration, and susceptibility to wear, corrosion, and infection. By enabling a gradual transition in composition and properties from a load-bearing metallic substrate to a bioactive surface, FGCs effectively mitigate interfacial stress concentrations and enhance long-term implant performance. This review provides a critical and comprehensive analysis of recent advances in FGCs for biomedical applications, focusing on material selection, fabrication techniques, and multifunctional performance. A wide range of material systems, including titanium-based alloys, bioactive ceramics such as hydroxyapatite, polymeric layers, and emerging nanocomposites, are systematically evaluated in terms of their mechanical, biological, and tribological behaviour. Fabrication methods such as plasma spraying, physical and chemical vapour deposition, laser-based processing, and additive manufacturing are comparatively assessed with respect to coating integrity, gradient control, scalability, and cost. Particular emphasis is placed on the role of gradient design in tailoring elastic modulus, enhancing adhesion strength, and controlling degradation and drug-release kinetics. The review further highlights the integration of advanced functionalities, including antibacterial activity, controlled drug delivery, and stimuli-responsive behaviour, which transform conventional implants into multifunctional therapeutic systems. Despite these advancements, significant challenges remain in achieving reproducible gradient architectures, ensuring long-term in vivo stability, and establishing standardized evaluation protocols. Critical research gaps are identified, particularly in the areas of multi-scale modelling, long-term clinical validation, and cost-effective manufacturing. Finally, future directions are outlined, emphasizing the potential of computational design, artificial intelligence-assisted optimization, and patient-specific fabrication approaches. This review aims to provide a structured framework for the rational design and development of next-generation FGCs, bridging the gap between laboratory-scale innovation and clinical translation.